SCHEMBL29540461

SCHEMBL29540461

CC(C)Cc1cc([Si](C)(C)C)cnc1-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SGK1 O00141 1/20 0.34
▸ CAMKK2 Q96RR4 1/20 0.34
▸ CKS1B P61024 2/20 0.34
▸ SKP1 P63208 2/20 0.34
▸ SKP2 Q13309 2/20 0.34
▸ ADK P55263 1/20 0.34
▸ NR4A2 P43354 2/20 0.33
▸ RXRA P19793 1/20 0.33
▸ PLK1 P53350 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.31
▸ KCNA5 P22460 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18073582 0.74 PDE10A (0.44) CKS1BSKP1SKP2ADORA1SMN1; SMN2
SCHEMBL17754243 0.71 ADORA3 (0.40) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL17637115 0.70 ADORA1 (0.38) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL25066775 0.69 LMNA (0.46) ADKADORA3ADORA2AADORA1SMN1; SMN2
SCHEMBL13883936 0.69 PDE10A (0.60) ADKPDE10A
SCHEMBL18729489 0.68 LDHA (0.41) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL17637117 0.66 KMO (0.37) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL18730284 0.66 LDHA (0.46) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL18730297 0.66 LDHA (0.50) SGK1CAMKK2ADORA3ADORA2AADORA2B
SCHEMBL12304043 0.65 ALOX15 (0.39) SGK1CAMKK2NR4A2RXRAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12101995-B2 Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-09-24 — — US disclosed
US-20220102652-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220102652-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE L1CAM, EML4, MSL1 SGK1 2894/4885CAMKK2 4050/4885CKS1B 3313/4885
US-12101995-B2 Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device L1CAM, MSL1, EML4 SGK1 3538/4885CAMKK2 4186/4885CKS1B 3401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback